Segui
Katrina Paumier
Katrina Paumier
Senior Director at Sage Therapeutics
Email verificata su sagerx.com
Titolo
Citata da
Citata da
Anno
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
BA Gordon, TM Blazey, Y Su, A Hari-Raj, A Dincer, S Flores, ...
The Lancet Neurology 17 (3), 241-250, 2018
6022018
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
V Ovod, KN Ramsey, KG Mawuenyega, JG Bollinger, T Hicks, ...
Alzheimer's & Dementia 13 (8), 841-849, 2017
5842017
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration
KL Paumier, KC Luk, FP Manfredsson, NM Kanaan, JW Lipton, TJ Collier, ...
Neurobiology of disease 82, 185-199, 2015
4292015
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
E McDade, G Wang, BA Gordon, J Hassenstab, TLS Benzinger, V Buckles, ...
Neurology 91 (14), e1295-e1306, 2018
3012018
The DIAN-TU Next Generation Alzheimer's prevention trial: adaptive design and disease progression model
RJ Bateman, TL Benzinger, S Berry, DB Clifford, C Duggan, AM Fagan, ...
Alzheimer's & Dementia 13 (1), 8-19, 2017
2952017
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
MF Duffy, TJ Collier, JR Patterson, CJ Kemp, KC Luk, MG Tansey, ...
Journal of neuroinflammation 15, 1-18, 2018
2222018
Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat
JH Kordower, HB Dodiya, AM Kordower, B Terpstra, K Paumier, ...
Neurobiology of disease 43 (3), 552-557, 2011
2152011
Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson’s disease
KL Paumier, SJ Sukoff Rizzo, Z Berger, Y Chen, C Gonzales, E Kaftan, ...
PloS one 8 (8), e70274, 2013
2102013
Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss
AL Spieles-Engemann, MM Behbehani, TJ Collier, SL Wohlgenant, ...
Neurobiology of disease 39 (1), 105-115, 2010
1482010
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease
TA Cole, H Zhao, TJ Collier, I Sandoval, CE Sortwell, K Steece-Collier, ...
JCI insight 6 (5), 2021
1072021
Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease
N Franzmeier, E Düzel, F Jessen, K Buerger, J Levin, M Duering, ...
Brain 141 (4), 1186-1200, 2018
1032018
Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein …
JR Patterson, MF Duffy, CJ Kemp, JW Howe, TJ Collier, AC Stoll, ...
Neurobiology of disease 130, 104525, 2019
942019
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM 2, neurodegeneration and cognitive decline
M Suárez‐Calvet, A Capell, MÁ Araque Caballero, E Morenas‐Rodríguez, ...
EMBO molecular medicine 10 (12), e9712, 2018
932018
Transplantation of subventricular zone neural precursors induces an endogenous precursor cell response in a rat model of Parkinson's disease
L Madhavan, BF Daley, KL Paumier, TJ Collier
Journal of Comparative Neurology 515 (1), 102-115, 2009
882009
Human A53T α-synuclein causes reversible deficits in mitochondrial function and dynamics in primary mouse cortical neurons
L Li, S Nadanaciva, Z Berger, W Shen, K Paumier, J Schwartz, K Mou, ...
PloS one 8 (12), e85815, 2013
662013
Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer’s disease
J Vöglein, K Paumier, M Jucker, O Preische, E McDade, J Hassenstab, ...
Brain 142 (5), 1429-1440, 2019
562019
Subthalamic nucleus deep brain stimulation employs trkB signaling for neuroprotection and functional restoration
DL Fischer, CJ Kemp, A Cole-Strauss, NK Polinski, KL Paumier, ...
Journal of Neuroscience 37 (28), 6786-6796, 2017
532017
Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease
KL Paumier, AD Siderowf, P Auinger, D Oakes, L Madhavan, AJ Espay, ...
Movement Disorders 27 (7), 880-887, 2012
532012
Inhibition of glucosylceramide synthase stimulates autophagy flux in neurons
W Shen, AG Henry, KL Paumier, L Li, K Mou, J Dunlop, Z Berger, ...
Journal of neurochemistry 129 (5), 884-894, 2014
472014
DIAN-TU Pharma Consortium for the Dominantly Inherited Alzheimer Network (2017) The DIAN-TU next generation Alzheimer’s prevention trial: adaptive design and disease …
RJ Bateman, TL Benzinger, S Berry, DB Clifford, C Duggan, AM Fagan, ...
Alzheimers Dement 13, 8-19, 0
45
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20